International Regulatory Collaboration on the Analysis of Nitrosamines in Metformin-Containing Medicines
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1550-7416
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
International Regulatory Collaboration on the Analysis of Nitrosamines in Metformin-Containing Medicines ; volume:24 ; number:3 ; day:21 ; month:4 ; year:2022 ; pages:1-9 ; date:5.2022
The AAPS journal / American Association of Pharmaceutical Scientists ; 24, Heft 3 (21.4.2022), 1-9, 5.2022
- Urheber
-
Keire, David A.
Bream, Robert
Wollein, Uwe
Schmaler-Ripcke, Jeannette
Burchardt, Annette
Conti, Massimiliano
Zmysłowski, Adam
Keizers, Peter
Morin, Justin
Poh, Jalene
George, Mark
Wierer, Michael
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1208/s12248-022-00702-4
- URN
-
urn:nbn:de:101:1-2022091815443877789462
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:37 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Keire, David A.
- Bream, Robert
- Wollein, Uwe
- Schmaler-Ripcke, Jeannette
- Burchardt, Annette
- Conti, Massimiliano
- Zmysłowski, Adam
- Keizers, Peter
- Morin, Justin
- Poh, Jalene
- George, Mark
- Wierer, Michael
- SpringerLink (Online service)
Ähnliche Objekte (12)
Correction: International Regulatory Collaboration on the Analysis of Nitrosamines in Metformin-Containing Medicines
Is Medicines Parallel Trade "Regulatory Arbitrage'"?
Is medicines parallel trade ‘regulatory arbitrage’?
Regulatory roadmap for nanotechnology based medicines
Regulatory Reform Outcomes and Accelerated Regulatory Pathways for New Prescription Medicines in Australia
Requirements for generic anti-epileptic medicines: a regulatory perspective
Essential medicines containing ethanol elevate blood acetaldehyde concentrations in neonates
Ocular medicines in children: the regulatory situation related to clinical research
Establishment of the African Medicines Agency: progress, challenges and regulatory readiness
Network medicines™
On the margins of aid orthodoxy: the Brazil-Mozambique collaboration to produce essential medicines in Africa
Regulatory, safety and economic considerations of over-the-counter medicines in the Indian population
Correction: International Regulatory Collaboration on the Analysis of Nitrosamines in Metformin-Containing Medicines
Is Medicines Parallel Trade "Regulatory Arbitrage'"?
Is medicines parallel trade ‘regulatory arbitrage’?
Regulatory roadmap for nanotechnology based medicines
Regulatory Reform Outcomes and Accelerated Regulatory Pathways for New Prescription Medicines in Australia
Requirements for generic anti-epileptic medicines: a regulatory perspective
Essential medicines containing ethanol elevate blood acetaldehyde concentrations in neonates
Ocular medicines in children: the regulatory situation related to clinical research
Establishment of the African Medicines Agency: progress, challenges and regulatory readiness
Network medicines™
On the margins of aid orthodoxy: the Brazil-Mozambique collaboration to produce essential medicines in Africa
Regulatory, safety and economic considerations of over-the-counter medicines in the Indian population
Correction: International Regulatory Collaboration on the Analysis of Nitrosamines in Metformin-Containing Medicines
Is Medicines Parallel Trade "Regulatory Arbitrage'"?
Is medicines parallel trade ‘regulatory arbitrage’?
Regulatory roadmap for nanotechnology based medicines
Regulatory Reform Outcomes and Accelerated Regulatory Pathways for New Prescription Medicines in Australia
Requirements for generic anti-epileptic medicines: a regulatory perspective
Essential medicines containing ethanol elevate blood acetaldehyde concentrations in neonates
Ocular medicines in children: the regulatory situation related to clinical research
Establishment of the African Medicines Agency: progress, challenges and regulatory readiness
Network medicines™
On the margins of aid orthodoxy: the Brazil-Mozambique collaboration to produce essential medicines in Africa